These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10572416)

  • 1. [Glucocorticoid treatment of ulcerative colitis].
    Okawa K; Aoki T; Oiya H; Okuno M
    Nihon Rinsho; 1999 Nov; 57(11):2481-5. PubMed ID: 10572416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on glucocorticoid receptor alpha and beta in colonic mucosal cell of patients with ulcerative colitis].
    Zhang H; Ouyang Q; Wen ZH; Liu WP; Chen DY; Li FY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):630-3. PubMed ID: 15460404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between the expression of the glucocorticoid receptor in biopsied colonic mucosa and the glucocorticoid responsiveness of ulcerative colitis patients.
    Fujishima S; Takeda H; Kawata S; Yamakawa M
    Clin Immunol; 2009 Nov; 133(2):208-17. PubMed ID: 19646928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inflammatory bowel disease--the role and issue of glucocorticoid].
    Ashida T
    Nihon Rinsho; 2008 Jan; 66(1):137-41. PubMed ID: 18186257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Activation of nuclear factor-kappaB and effects of anti-inflammatory treatment thereon in intestinal mucosa of patients with ulcerative colitis].
    Gan H; Ouyang Q; Chen Y; Xia Q
    Zhonghua Yi Xue Za Zhi; 2002 Mar; 82(6):384-8. PubMed ID: 11953203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanisms of the anti-inflammatory action of glucocorticoids].
    Belovezhdov N
    Vutr Boles; 1985; 24(6):1-5. PubMed ID: 3913140
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular mechanisms of glucocorticoid resistance.
    Bantel H; Domschke W; Schulze-Osthoff K
    Gastroenterology; 2000 Oct; 119(4):1178-9. PubMed ID: 11203033
    [No Abstract]   [Full Text] [Related]  

  • 8. A review of infliximab use in ulcerative colitis.
    Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
    Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Salazosulfapyridine and 5-aminosalicylic acid agents for the treatment of ulcerative colitis].
    Aihara H; Hiwatashi N
    Nihon Rinsho; 1999 Nov; 57(11):2476-80. PubMed ID: 10572415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MIF as a glucocorticoid-induced modulator of cytokine production.
    Calandra T; Bernhagen J; Metz CN; Spiegel LA; Bacher M; Donnelly T; Cerami A; Bucala R
    Nature; 1995 Sep; 377(6544):68-71. PubMed ID: 7659164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of glucocorticoid receptor beta in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis.
    Honda M; Orii F; Ayabe T; Imai S; Ashida T; Obara T; Kohgo Y
    Gastroenterology; 2000 May; 118(5):859-66. PubMed ID: 10784585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression.
    Löwenberg M; Verhaar AP; van den Brink GR; Hommes DW
    Trends Mol Med; 2007 Apr; 13(4):158-63. PubMed ID: 17293163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cyclosporine treatment of patients with active ulcerative colitis refractory to high-dose glucocorticoid].
    Kjeldsen J; Wilson BV; Knudsen T
    Ugeskr Laeger; 2001 Jan; 163(1):22-5. PubMed ID: 11586667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid receptors and glucocorticoid-sensitive secretion of neutral proteinases in a macrophage line.
    Werb Z; Foley R; Munck A
    J Immunol; 1978 Jul; 121(1):115-21. PubMed ID: 209106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoids: mechanisms of action and anti-inflammatory potential in asthma.
    van der Velden VH
    Mediators Inflamm; 1998; 7(4):229-37. PubMed ID: 9792333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell glucocorticoid receptor is required to suppress COX-2-mediated lethal immune activation.
    Brewer JA; Khor B; Vogt SK; Muglia LM; Fujiwara H; Haegele KE; Sleckman BP; Muglia LJ
    Nat Med; 2003 Oct; 9(10):1318-22. PubMed ID: 12949501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between glucocorticoid receptor and response to glucocorticoid therapy in ulcerative colitis.
    Shimada T; Hiwatashi N; Yamazaki H; Kinouchi Y; Toyota T
    Dis Colon Rectum; 1997 Oct; 40(10 Suppl):S54-8. PubMed ID: 9378013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
    Moriconi F; Raddatz D; Ho NA; Yeruva S; Dudas J; Ramadori G
    Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic and nongenomic effects of glucocorticoids.
    Stahn C; Buttgereit F
    Nat Clin Pract Rheumatol; 2008 Oct; 4(10):525-33. PubMed ID: 18762788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proceedings: Immunosuppressive consequences of the treatment of ulcerative colitis with azathioprine.
    Skinner JM; Campbell AC; Waller C; Wood J; MacLennan IC
    Gut; 1974 Oct; 15(10):828-9. PubMed ID: 4611752
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.